Page last updated: 2024-08-18

pyrroles and dm 235

pyrroles has been researched along with dm 235 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartolini, A; Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Pittaluga, A; Pugliese, AM; Romanelli, MN1
Dei, S; Galeotti, N; Ghelardini, C; Guandalini, L; Manetti, D; Martelli, C; Martini, E; Novella Romanelli, M; Scapecchi, S; Teodori, E1
Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Martini, E; Romanelli, MN1
Dei, S; Ghelardini, C; Guandalini, L; Manetti, D; Martini, E; Melchiorre, M; Norcini, M; Pagella, S; Romanelli, MN; Scapecchi, S; Teodori, E1
Bartolucci, G; Dei, S; Di Cesare Mannelli, L; Floriddia, E; Ghelardini, C; Guandalini, L; Malik, R; Manetti, D; Martino, MV; Melani, F; Orlandi, F; Romanelli, MN; Teodori, E1
Gualtieri, F1

Reviews

2 review(s) available for pyrroles and dm 235

ArticleYear
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.
    CNS drug reviews, 2006,Spring, Volume: 12, Issue:1

    Topics: Animals; Central Nervous System; Cognition; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Nootropic Agents; Piperazines; Pyrroles; Synaptic Transmission

2006
Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings.
    Journal of enzyme inhibition and medicinal chemistry, 2016, Volume: 31, Issue:2

    Topics: Animals; Cognition; Drug Evaluation, Preclinical; Humans; Internet; Nootropic Agents; Patents as Topic; Piperazines; Pyrroles; Structure-Activity Relationship

2016

Other Studies

4 other study(ies) available for pyrroles and dm 235

ArticleYear
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).
    Naunyn-Schmiedeberg's archives of pharmacology, 2003, Volume: 368, Issue:6

    Topics: Amnesia; Animals; Avoidance Learning; Cognition; Dose-Response Relationship, Drug; Electrophysiology; Hippocampus; Kynurenic Acid; Male; Mice; N-Methylaspartate; Nootropic Agents; Piperazines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

2003
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
    Bioorganic & medicinal chemistry, 2004, Jan-02, Volume: 12, Issue:1

    Topics: Animals; Avoidance Learning; Dose-Response Relationship, Drug; Mice; Nootropic Agents; Pain Measurement; Pain Threshold; Piperazines; Pyrroles; Rats; Structure-Activity Relationship

2004
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
    Bioorganic & medicinal chemistry, 2008, Dec-01, Volume: 16, Issue:23

    Topics: Animals; Avoidance Learning; Data Interpretation, Statistical; Drug Design; Mice; Nootropic Agents; Piperazines; Pyrroles; Recognition, Psychology

2008
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
    Bioorganic & medicinal chemistry letters, 2015, Apr-15, Volume: 25, Issue:8

    Topics: Amnesia; Animals; Avoidance Learning; Mice; Nootropic Agents; Piperazines; Pyrroles; Stereoisomerism; Structure-Activity Relationship

2015